Table 3.
ACG | ACG description | N | % | Cost* | CV | Outliers† |
4100 | 2-3 Other ADG Combinations, Age 35+ | 28 864 | 12.7 | 776.3 | 107 | 6.5 |
0300 | Acute Minor, Age 6+ | 26 909 | 11.8 | 169.6 | 139 | 6.6 |
4910 | 6-9 Other ADG Combinations, Age 35+, 0-1 Major ADGs | 14 876 | 6.5 | 1624.4 | 67 | 4.5 |
2100 | Acute Minor/Likely to Recur, Age 6+, w/o Allergy | 11 867 | 5.2 | 304.7 | 91 | 5.3 |
4410 | 4-5 Other ADG Combinations, Age 45+, no Major ADGs | 10 551 | 4.6 | 1025.4 | 74 | 5.3 |
4420 | 4-5 Other ADG Combinations, Age 45+, 1 Major ADGs | 10 137 | 4.5 | 1336.2 | 79 | 4.6 |
0500 | Likely to Recur, w/o Allergies | 9872 | 4.3 | 187.2 | 140 | 6.6 |
1800 | Acute Minor/Acute Major | 9077 | 4.0 | 353.2 | 104 | 5.9 |
1600 | Preventive/Administrative | 8527 | 3.8 | 229.5 | 215 | 12.5 |
0400 | Acute Major | 8160 | 3.6 | 237.3 | 160 | 8.1 |
0900 | Chronic Medical: Stable | 6319 | 2.8 | 506.7 | 114 | 6.2 |
3900 | 2-3 Other ADG Combinations, Males Age 18 to 34 | 5877 | 2.6 | 341.7 | 117 | 6.0 |
3200 | Acute Minor/Acute Major/Likely to Recur, Age 12+, w/o Allergy | 5785 | 2.5 | 525.0 | 89 | 6.3 |
2300 | Acute Minor/Chronic Medical: Stable | 5756 | 2.5 | 612.6 | 95 | 6.3 |
3600 | Acute Minor/Acute Major/Likely to Recur/Chronic Medical: Stable | 5575 | 2.5 | 1022.1 | 72 | 5.0 |
4310 | 4-5 Other ADG Combinations, Age 18 to 44, no Major ADGs | 4168 | 1.8 | 554.8 | 86 | 6.4 |
4920 | 6-9 Other ADG Combinations, Age 35+, 2 Major ADGs | 4089 | 1.8 | 2102.5 | 67 | 3.5 |
2800 | Acute Major/Likely to Recur | 3659 | 1.6 | 351.0 | 102 | 6.9 |
1300 | Psychosocial, w/o Psychosocial Unstable | 3653 | 1.6 | 340.4 | 175 | 10.7 |
Nineteen ACG categories contain 80.9% of patients (N=183 721). No patient was grouped in 37 ACG categories; ACG, Adjusted Clinical Groups (Code)*: Gross cost (mean/unit in euros), CV: Pearson's coefficient of variation† :outliers: percentage of patients, cut-off: T = Q3 + 1.5 (Q3 − Q1), where Q3 and Q1 are the third and first quartiles of the distribution, respectively. Total sample: N=227 235, CV =130.0%, outliers: 6.2%.